Main Topic Area
- Radiation Therapy
Radiation therapy is a cancer treatment that uses high-energy x-rays or other types of radiation to kill cancer cells. T...
All Topic Areas
1 - 10 of 274 more >>
Articles
1 - 5 of 30 more >>
- Hydroxyurea Therapy Improves Survival in Most Severely Affected Sickle Cell Patients
Sickle cell anemia patients who took the drug hydroxyurea over a 9-year period experienced a 40 percent reduction in deaths, according to the first study to evaluate whether the treatment prolongs life, announced the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health. The study of 299 adult sickle cell patients with moderate to severe forms of the disease, found that improved survival was related to the benefits associated with hydroxyurea treatment an...
National Institutes of Health
- Gene Therapy for Cancer: Questions and Answers
Key Points Gene therapy is an experimental treatment that involves introducing genetic material into a person’s cells to fight disease (see Question 2). Researchers are studying gene therapy for cancer through a number of different approaches (see Question 3). A gene can be delivered to a cell using a carrier known as a “vector.” The most common types of vectors used in gene therapy are viruses (see Question 4). The viruses used in gene therapy are altered to make them safe;...
- FDA Approves First New Drug Application for Treatment of Radiation Contamination due to Cesium or Thallium
This is a revised version of FDA Press Release P03-75, originally issued earlier on Oct. 2, 2003. Corrections were made to the original version, which is now obsolete. The Food and Drug Administration (FDA) today approved a New Drug Application for Radiogardase, also known as Prussian blue, to treat people exposed to radiation contamination, due to harmful levels of cesium-137 or thallium. Radiogardase capsules contain Ferric (III) hexacyanoferrate(II). The approval of Radiogardase is part of...
U.S. Food and Drug Administration
- Oral Complications of Chemotherapy and Radiation
This patient summary on oral complications of cancer and cancer therapy is adapted from the summary written for health professionals by cancer experts. This and other accurate, credible information about cancer treatment, screening, prevention, supportive care, and ongoing clinical trials is available from the National Cancer Institute. Oral complications are common in cancer patients, especially those with head and neck cancer. This summary describes oral complications caused by chemotherapy...
National Cancer Institute
- Small Trial Shows Daclizumab Add-On Therapy
Improves Multiple Sclerosis Outcome
A small clinical trial of patients with multiple sclerosis (MS) who did not respond to interferon alone found that adding the human antibody daclizumab improved patient outcome. Patients who received the combined therapy had a 78 percent reduction in new brain lesions and a 70 percent reduction in total lesions, along with other significant clinical improvements. The trial was led by investigators at the National Institute of Neurological Disorders and Stroke (NINDS), a component of the...
National Institutes of Health
Organizations
1 - 5 of 12 more >>
- Radiation Therapy Oncology Group -
- Office of Air and Radiation, EPA - http://www.epa.gov/oar/oarhome.html
- National Council on Radiation Protection and Measurements - http://www.ncrp.com/
- Radiation Internal Dose Information Center - http://dwb.unl.edu/Teacher/NSF/C03/C03Links/www.orau.gov/ehsd/ridic.htm
- Environmental Protection Agency, Office of Air and Radiation -
News
1 - 5 of 2856 more >>
- Radiation information available in Spanish
The Earth Times - Fri, 23 Feb 2007 10:19 EST
- Prostate Cancer: Radiation Not Best
WebMD - Mon, 26 Feb 2007 07:49 EST
- Breast Cancer Survivors Experience Long-term Heart Disease Risk From Radiotherapy
ScienceDaily - Wed, 07 Mar 2007 04:00 EST
- Breast, Prostate Cancer Resources Now Available In Spanish
MedicalNewsToday - Thu, 22 Feb 2007 11:00 EST
- External Radiation for Prostate Cancer May Have Lower Survival Rate
WebMD - Mon, 26 Feb 2007 12:00 EST
Clinical Trials
1 - 5 of 6394 more >>
- Mometasone Furoate in Preventing Radiation Dermatitis in Patients Undergoing Radiation Therapy to the Breast or Chest Wall for Invasive Breast Cancer or Ductal Carcinoma in Situ
ClinicalTrials.gov Identifier: NCT00438659 - Active, not recruiting
Breast Cancer; Dermatologic Complications; Radiation Toxicity; Skin Reactions Secondary to Radiation Therapy
- Parotid-Sparing Intensity-Modulated Radiation Therapy Compared With Conventional Radiation Therapy in Treating Patients With Oropharyngeal or Hypopharyngeal Cancer Who Are at High Risk of Radiation-Induced Xerostomia
ClinicalTrials.gov Identifier: NCT00081029 - Recruiting
Hypopharyngeal Cancer; oral complications of chemotherapy and head and neck radiation; Oropharyngeal Cancer; radiation toxicity
- Glutamine in Treating Mucositis Caused by Radiation Therapy in Patients With Newly Diagnosed Cancer of the Mouth or Throat
ClinicalTrials.gov Identifier: NCT00006994 - Active, not recruiting
lip and oral cavity cancer; oral complications of chemotherapy and head and neck radiation; Oropharyngeal Cancer; Pain; radiation toxicity
- Radiation Therapy With or Without Thalidomide in Treating Patients With Brain Metastases
ClinicalTrials.gov Identifier: NCT00033254 - Active, not recruiting
brain metastases
- Radiation Therapy and Cisplatin With or Without Epoetin Alfa in Treating Patients With Cervical Cancer and Anemia
ClinicalTrials.gov Identifier: NCT00017004 - Active, not recruiting
Anemia; Cervical Cancer; Drug Toxicity; Quality of Life; radiation toxicity

Not Signed In -

